ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Fatty acid binding protein 4 has prognostic value in peripheral artery disease

Li, Ben; Zamzam, Abdelrahman; Syed, Muzammil H.; Djahanpour, Niousha; Jain, Shubha; Abdin, Rawand; Qadura, Mohammad*
Journal of Vascular Surgery2023-9DOI: 10.1016/j.jvs.2023.05.001
5被引1阅读
引用收藏
分享

摘要

Objective: Peripheral artery disease (PAD) remains undertreated, despite its association with major amputation and mortality. This is partly due to a lack of available disease biomarkers. The intracellular protein fatty acid binding protein 4 (FABP4) is implicated in diabetes, obesity, and metabolic syndrome. Given that these risk factors are strong contributors to vascular disease, we assessed the prognostic ability of FABP4 in predicting PAD-related adverse limb events. Methods: This was a prospective case-control study with 3 years of follow-up. Baseline serum FABP4 concentrations were measured in patients with PAD (n = 569) and without PAD (n = 279). The primary outcome was major adverse limb event (MALE; defined as a composite of vascular intervention or major amputation). The secondary outcome was worsening PAD status (drop in ankle-brachial index >= 0.15). Kaplan-Meier and Cox proportional hazards analyses adjusted for baseline characteristics were conducted to assess the ability of FABP4 to predict MALE and worsening PAD status. Results: Patients with PAD were older and more likely to have cardiovascular risk factors compared with those without PAD. Over the study period, MALE and worsening PAD status occurred in 162 (19%) and 92 (11%) patients, respectively. Higher FABP4 levels were significantly associated with 3-year MALE (unadjusted hazard ratio [HR], 1.19; 95% confidence interval [CI], 1.04-1.27; adjusted HR, 1.18; 95% CI, 1.03-1.27; P =.022) and worsening PAD status (unadjusted HR, 1.18; 95% CI, 1.13-1.31; adjusted HR, 1.17; 95% CI, 1.12-1.28; P <.001). Three-year Kaplan-Meier survival analysis demonstrated that patients with high FABP4 levels had a decreased freedom from MALE (75% vs 88%; log rank = 22.6; P <.001), vascular intervention (77% vs 89%; log rank = 20.8; P <.001), and worsening PAD status (87% vs 91%; log rank = 6.16; P =.013). Conclusions: Individuals with higher serum concentrations of FABP4 are more likely to develop PAD-related adverse limb events. FABP4 has prognostic value in risk-stratifying patients for further vascular evaluation and management. (J Vasc Surg 2023;78:719-26.)

学科与关键词

关键词
Fatty acid binding protein 4Major adverse limb eventPeripheral artery diseasePrognosis
相关
加载中…
  • Development and evaluation of a prediction model for peripheral artery disease-related major adverse limb events using novel biomarker data
    Li, Ben; Nassereldine, Rakan; Zamzam, Abdelrahman; Syed, Muzammil H.; Mamdani, Muhammad; Al-Omran, Mohammed; Abdin, Rawand; Qadura, Mohammad*Journal of Vascular Surgery, 2024, 80(2).被引 3
  • A machine learning algorithm for peripheral artery disease prognosis using biomarker data
    Li, Ben; Shaikh, Farah; Zamzam, Abdelrahman; Syed, Muzammil H.; Abdin, Rawand; Qadura, Mohammad*iScience, 2024, 27(3): 109081.被引 6
  • Serum Legumain Is Associated with Peripheral Artery Disease in Patients with Type 2 Diabetes
    Wei, Wen; Chen, Shujin; Huang, Jianqing; Tong, Yan; Zhang, Jushun; Qiu, Xiuping; Zhang, Wenrui; Chen, Hangju; Huang, Rong; Cai, Jin; Tu, Mei*Journal of Diabetes Research, 2021, 2021: 5651469.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Vascular Surgery
发表日期
2023-09
卷期
第 78 卷, 第 3 期
页码
719-726
DOI
10.1016/j.jvs.2023.05.001
语言
ENGLISH
成果收录
SCIE
资助标注
Blair Foundation

作者

  • L

    Li, Ben (第一作者)

  • Z

    Zamzam, Abdelrahman

查看全部 7 位作者收起作者
  • S

    Syed, Muzammil H.

  • D

    Djahanpour, Niousha

  • J

    Jain, Shubha

  • A

    Abdin, Rawand

  • Q

    Qadura, Mohammad (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417